Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | ALOX12 | P18054 | 3/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.50 |
| ▸ | BRCA1 | P38398 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.50 |
| ▸ | FTO | Q9C0B1 | 10/20 | 0.49 |
| ▸ | MAPT | P10636 | 3/20 | 0.49 |
| ▸ | MEN1 | O00255 | 2/20 | 0.49 |
| ▸ | HTT | P42858 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | RECQL | P46063 | 1/20 | 0.49 |
| ▸ | BLM | P54132 | 1/20 | 0.49 |
| ▸ | SMAD3 | P84022 | 1/20 | 0.49 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.49 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2989053 | 0.83 | HPGD (0.53) | HPGDALDH1A1ALOX12CYP2C9ALOX15 | |
| SCHEMBL6037012 | 0.82 | ALDH1A1 (0.56) | HPGDALDH1A1ALOX12CYP2C9ALOX15 | |
| SCHEMBL6535901 | 0.81 | HPGD (0.55) | HPGDALDH1A1ALOX12CYP2C9ALOX15 | |
| SCHEMBL2877720 | 0.79 | HPGD (0.51) | HPGDALDH1A1ALOX12CYP2C9ALOX15 | |
| SCHEMBL3282095 | 0.79 | HPGD (0.51) | HPGDALDH1A1ALOX12CYP2C9ALOX15 | |
| SCHEMBL2407742 | 0.78 | HPGD (0.52) | HPGDALDH1A1ALOX12CYP2C9ALOX15 | |
| SCHEMBL1986259 | 0.77 | HPGD (0.49) | HPGDALDH1A1ALOX12CYP2C9ALOX15 | |
| SCHEMBL4802179 | 0.77 | HPGD (0.51) | HPGDALDH1A1ALOX12CYP2C9ALOX15 | |
| SCHEMBL213292 | 0.76 | HPGD (0.53) | HPGDALDH1A1ALOX12CYP2C9ALOX15 | |
| SCHEMBL7907421 | 0.76 | ALDH1A1 (0.53) | HPGDALDH1A1ALOX12CYP2C9ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2684963-B1 | METHOD FOR SCREENING FOR COMPOUND CAPABLE OF ENHANCING OR INHIBITING OATP1B1 TRANSPORT ACTIVITY, AND METHOD FOR DETERMINING EXPRESSION LEVEL OF OATP1B1 | EISAI R&D MAN CO LTD (JP) | 2016-02-03 | — | — | EP | disclosed |
| EP-2684963-A1 | METHOD FOR SCREENING FOR COMPOUND CAPABLE OF ENHANCING OR INHIBITING OATP1B1 TRANSPORT ACTIVITY, AND METHOD FOR DETERMINING EXPRESSION LEVEL OF OATP1B1 | Eisai R&D Management Co., Ltd. (JP) | 2014-01-15 | — | — | EP | disclosed |
| US-20120003639-A1 | CANCER BIOMARKERS AND METHODS OF USE THEREOF | PRELUDE, INC. (US) | 2012-01-05 | — | — | US | disclosed |
| US-7910097-B2 | Lymphatic endothelial glycoprotein for use as tool in identifying modulators for prevention and treatment of inflammation and cell proliferative disorders | FARON PHARMACEUTICALS OY (FI) | 2011-03-22 | — | — | US | disclosed |
| US-20090191131-A1 | USE OF PARTICULATE CONTRAST AGENTS IN DIAGNOSTIC IMAGING FOR STUDYING PHYSIOLOGICAL PARAMATERS | FOSSHEIM SIGRID LISE | 2009-07-30 | — | — | US | disclosed |
| WO-2009010766-A1 | METHOD | UNIVERSITY OF THE WEST OF ENGLAND, BRISTOL (GB) | 2009-01-22 | — | — | WO | disclosed |
| US-20080267958-A1 | Common lymphatic endothelial and vascular endothelial receptor-1 (CLEVER-1) and uses thereof | FARON PHARMACEUTICALS OY | 2008-10-30 | — | — | US | disclosed |
| US-7354577-B2 | Common lymphatic endothelial and vascular endothelial receptor-1 (CLEVER-1) and uses thereof | FARON PHARMACEUTICALS OY (FI) | 2008-04-08 | — | — | US | disclosed |
| EP-1463760-B1 | COMMON LYMPHATIC ENDOTHELIAL AND VASCULAR ENDOTHELIAL RECEPTOR-1 (CLEVER-1) AND USES THEREOF | FARON PHARMACEUTICALS OY (FI) | 2007-09-05 | — | — | EP | disclosed |
| US-20050136002-A1 | Use of particulate contrast agents in diagnostic imaging for studying physiological paramaters | GE HEALTHCARE AS (NO) | 2005-06-23 | — | — | US | disclosed |
| US-20050069888-A1 | Common lymphatic endothelial and vascular endothelial receptor-1 (clever-1) and uses thereof | FARON PHARMACEUTICALS OY (FI) | 2005-03-31 | — | — | US | disclosed |
| EP-1463760-A2 | COMMON LYMPHATIC ENDOTHELIAL AND VASCULAR ENDOTHELIAL RECEPTOR-1 (CLEVER-1) AND USES THEREOF | JALKANEN, Sirpa (FI) | 2004-10-06 | — | — | EP | disclosed |
| EP-1069888-B1 | USE OF PARTICULATE CONTRAST AGENTS IN DIAGNOSTIC IMAGING FOR STUDYING PHYSIOLOGICAL PARAMETERS | AMERSHAM HEALTH AS (NO) | 2004-09-22 | — | — | EP | disclosed |
| WO-2003057130-A2 | COMMON LYMPHATIC ENDOTHELIAL AND VASCULAR ENDOTHELIAL RECEPTOR-1 (CLEVER-1) AND USES THEREOF | JALKANEN SIRPA (FI) | 2003-07-17 | — | — | WO | disclosed |
| EP-1100956-A2 | PROCESS FOR IDENTIFICATION OF SUBSTANCES MODULATING UREI DEPENDENT MECHANISMS OF HELICOBACTER PYLORI METABOLISM | Byk Gulden Lomberg Chemische Fabrik GmbH (DE) | 2001-05-23 | — | — | EP | disclosed |
| WO-2000008204-A2 | PROCESS FOR IDENTIFICATION OF SUBSTANCES MODULATING UREI DEPENDENT MECHANISMS OF HELICOBACTER PYLORI METABOLISM | BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) | 2000-02-17 | — | — | WO | disclosed |
| US-5942409-A | Process for identification of substances modulating ureI dependent mechanisms of Helicobacter pylori metabolism | BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) | 1999-08-24 | — | — | US | disclosed |
| US-4945171-A | FLUORESCENT DYES | MOLECULAR PROBES, INC. (US) | 1990-07-31 | — | — | US | disclosed |
| EP-0221768-A2 | Detection of T-cell activation | DANA-FARBER CANCER INSTITUTE, INC. (US) | 1987-05-13 | — | — | EP | disclosed |